Contents
Download PDF
pdf Download XML
941 Views
122 Downloads
Share this article
Research Article | Volume 13 Issue:2 (, 2023) | Pages 254 - 257
Mycobacterium w, New Hope to Sepsis Patients: Initial Experience from Single center
Under a Creative Commons license
Open Access
DOI : 10.5083/ejcm
Published
April 20, 2023
Abstract

Background: Mycobacterium wis an immunomodulatorthat evokes antigen-specific cell-mediated immunity and its use has been evaluated in patients with sepsis, where it resulted in improved outcome.  Methods: We collected data in ten adult patientswith suspected gram-negative sepsis admitted inthe intensive care unit. Injection Mw 0.3 ml was administered intradermal per day for three consecutive days alongwith continuation of standard care. Results: We observed clinical improvement and a significant decrease in TLC and SOFA Score on day 7 after Mw administration. Also, Mw was not associated with any local or systemic adverse effects. Conclusion: The use of Mw was safe and effective in patients with sepsis, though larger randomized trials are required to establish its role.

Keywords
Recommended Articles
Research Article
Comparative Evaluation of Cognitive Function in Patients with Schizophrenia Versus Bipolar Disorder: A Cross-Sectional Study
Published: 14/04/2024
Download PDF
Research Article
Association of Serum Albumin-to-Globulin Ratio with Left Ventricular Diastolic Dysfunction in Patients with Essential Hypertension: A Prospective Observational Study
...
Published: 29/10/2026
Download PDF
Research Article
Substance Use Disorders and Aggressive Behaviour Among Individuals Referred for Medico-Legal Psychiatric Evaluation: A Cross-Sectional Study.
Published: 23/04/2024
Download PDF
Research Article
A Comparative Study of Psychiatric Morbidity in Patients with Substance Use Disorder and Non-Substance Users.
Published: 08/11/2024
Download PDF
Chat on WhatsApp
Copyright © EJCM Publisher. All Rights Reserved.